Signaling	NN
pathways	NNS
and	CC
their	PRP$
miRNA	NNP
regulators	NNS
involved	VBN
in	IN
the	DT
etiopathology	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
and	CC
hypersensitivity	NN
pneumonitis	NN
(	(
HP	NNP
)	)
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
and	CC
hypersensitivity	NN
pneumonitis	NN
(	(
HP	NNP
)	)
belong	VBP
to	TO
heterogenic	JJ
group	NN
of	IN
interstitial	JJ
lung	NN
diseases	NNS
(	(
ILD	NNS
)	)
.	.

For	IN
the	DT
reason	NN
that	IN
this	DT
group	NN
of	IN
diseases	NNS
present	JJ
with	IN
complex	JJ
clinical	JJ
non-specific	JJ
features	NNS
,	,
they	PRP
represent	VBP
a	DT
diagnostic	JJ
and	CC
therapeutic	JJ
challenge	NN
.	.

In	IN
this	DT
review	NN
we	PRP
focus	VBP
on	IN
several	JJ
crucial	JJ
signaling	NN
pathways	NNS
participating	VBG
in	IN
inflammation	NN
,	,
fibrosis	NN
and	CC
EMT	NN
processes	NNS
,	,
so	RB
important	JJ
in	IN
the	DT
course	NN
of	IN
ILD	NNP
:	:
TNF-a/NFkb	NN
,	,
TGF-b/SMAD	NN
,	,
Wnt-b-catenin	NN
and	CC
PI3K-Akt	NN
signaling	NN
.	.

Moreover	RB
,	,
this	DT
review	NN
summarizes	VBZ
the	DT
role	NN
of	IN
selected	VBN
signaling	NN
pathways	NNS
and	CC
some	DT
miRNAs	NNS
which	WDT
are	VBP
their	PRP$
regulators	NNS
during	IN
development	NN
and	CC
progression	NN
of	IN
IPF	NN
and	CC
HP	NNP
.	.

Recent	JJ
advances	NNS
indicate	VBP
the	DT
potential	JJ
role	NN
of	IN
miRNAs	NNS
as	IN
a	DT
molecular	JJ
markers	NNS
differentiating	VBG
clinical	JJ
course	NN
of	IN
ILD	NNP
.	.

